Literature DB >> 20962024

Loss of the C terminus of melanocortin receptor 2 (MC2R) results in impaired cell surface expression and ACTH insensitivity.

Andrea Hirsch1, Eirini Meimaridou, Monica Fernandez-Cancio, Amit V Pandey, María Clemente, Laura Audi, Adrian J L Clark, Christa E Flück.   

Abstract

OBJECTIVE: Mutations in melanocortin receptor 2 (MC2R) and its related melanocortin receptor accessory protein (MRAP) cause familial glucocorticoid deficiency. We identified a novel MC2R mutation, K289fs. This unique mutation in the C terminus of MC2R is located in the intracellular part of the protein for which the exact function is unknown.
SETTING: A 6-wk-old boy presented with severe hypoglycemia, unmeasurable cortisol, and grossly elevated ACTH but normal electrolytes. Genetic analysis revealed homozygote K289fs mutation in MC2R. His parents and siblings were heterozygous but phenotypically normal. INTERVENTION AND
RESULTS: The role of the C terminus of MC2R was studied in two cell systems. Because the K289fs mutant changes the last eight amino acids of the protein and leads to protein elongation, wild-type MC2R and C-terminally mutated constructs were tested for activity to respond to ACTH in an OS3 cell-based reporter assay. Wild-type and alanine-substituted constructs responded normally to ACTH. By contrast K289fs and M290X had a total loss of activity. Cell surface assays and confocal localization studies revealed that K289fs and M290X receptors were not found at the cell surface, indicating that their transport from the endoplasmic reticulum to the cell membrane is disrupted. Interestingly, coimmunoprecipitation experiments showed no alteration in the interaction of mutant MC2R with MRAP, suggesting that interaction between these two proteins does not guarantee normal localization.
CONCLUSIONS: Loss of the C terminus of MC2R impairs cell surface expression and ACTH sensitivity but does not disrupt interaction of MC2R with MRAP. These findings highlight the extreme sensitivity of MC2R to structural disruption.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962024     DOI: 10.1210/jc.2010-1056

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia.

Authors:  Christa E Flück; Amit V Pandey; Bernhard Dick; Núria Camats; Mónica Fernández-Cancio; María Clemente; Miquel Gussinyé; Antonio Carrascosa; Primus E Mullis; Laura Audi
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

Review 2.  ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

Authors:  Davids Fridmanis; Ance Roga; Janis Klovins
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-06       Impact factor: 5.555

3.  Differential regulation of human 3β-hydroxysteroid dehydrogenase type 2 for steroid hormone biosynthesis by starvation and cyclic AMP stimulation: studies in the human adrenal NCI-H295R cell model.

Authors:  Sameer Udhane; Petra Kempna; Gaby Hofer; Primus E Mullis; Christa E Flück
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.